about
A linearization approach for the model-based analysis of combined aggregate and individual patient data.Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation.Missing data in model-based pharmacometric applications: points to consider.Estimating transformations for repeated measures modeling of continuous bounded outcome data.Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study.Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.Disease progression meta-analysis model in Alzheimer's disease.Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.A case study of model-based Bayesian dose response estimation.Extending the latent variable model for extra correlated longitudinal dichotomous responses.Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database.Generalized additive models for cancer mapping with incomplete covariates.Characterizing dose-response relationships in multiple cancer bioassays.A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
P50
Q30746912-32E9271D-E5B2-466B-8B72-4EA5120E6CC5Q33548385-63716AB0-22A1-4A47-B190-F19FE8412D93Q33706156-6C762E53-238A-41F8-9DD1-8BADEFD6EB19Q33864905-A8D60496-207B-4513-A707-841D280B8E42Q34181788-9447CB15-8BAB-4460-B2B3-740A67CFD15DQ34624337-7CF79D74-D3AF-4C2A-AE10-0D21D12986EDQ37547605-F543D31A-AAAA-4D21-A13B-BC82FA348A19Q38666988-D661F345-776A-4B34-B3AE-7A685BB71719Q43900660-A04E906B-ABE9-47FF-BE23-9F2DB4C980A3Q46443885-ED5B76C8-54F9-429F-9A7C-75F5A5425758Q51664967-A1B9B294-39B4-4B1A-81A7-F5A498E59F17Q52000396-4D7DC441-3A85-408D-BB13-D7FACC8FB838Q52064587-19F51097-8F4B-46AF-B11A-8828C9511E72Q82066071-F768A3B1-037C-4B9B-8EFB-58AF4992C627
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan French
@ast
Jonathan French
@en
Jonathan French
@es
Jonathan French
@nl
type
label
Jonathan French
@ast
Jonathan French
@en
Jonathan French
@es
Jonathan French
@nl
prefLabel
Jonathan French
@ast
Jonathan French
@en
Jonathan French
@es
Jonathan French
@nl
P106
P21
P31
P496
0000-0001-9649-169X